首頁 > 市場調查報告書 > 製藥

開發平台分析

市場調查報告書

商品編碼

1741208

巨噬細胞標記物市場按標記物類型、應用、疾病領域、最終用戶和地區分類

Macrophage Marker Market, By Marker Type, By Application, By Disease Area, By End User, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

巨噬細胞標記市場規模預計在 2025 年為 2.903 億美元，預計到 2032 年將達到 4.511 億美元，2025 年至 2032 年的年複合成長率為 6.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	2.903億美元
效能數據	2020-2024	預測期	2025-2032
預測期間：2025年至2032年的年複合成長率	6.50%	2032年價值預測	4.511億美元

巨噬細胞是在免疫和體內平衡中發揮關鍵作用的白血球。它們是吞噬異物、微生物和碎片的第一個反應者。由於其重要性，表徵和研究巨噬細胞的生物學至關重要。巨噬細胞標記使研究人員能夠識別、分離、追蹤和標靶化這些細胞。巨噬細胞標記主要有兩種類型。第一種類型是細胞表面標誌物標記物，它們是在巨噬細胞外膜上表現的蛋白質，可以使用螢光活化細胞分選或免疫組織化學檢測。常見的巨噬細胞表面標誌物包括 CD68、CD14、CD163 和 CD206。第二種是細胞內標記物，它們是存在於巨噬細胞內部的蛋白質。

細胞內標記提供有關巨噬細胞活化和功能的資訊，但需要細胞固定和透化。細胞表面標誌物的優點在於可以進行活細胞分析、分離和標靶化巨噬細胞。然而，沒有一種標記物特異性足夠強，能夠唯一地識別巨噬細胞，且標記物的表達會因活化狀態和組織環境而異。為了準確表徵巨噬細胞表現型和細胞群，多種標記的組合是理想的選擇。全球市場提供各種針對巨噬細胞標記的單株抗體，有助於基礎研究和應用研究，從而尋找跨疾病狀態的新治療策略。

市場動態

免疫學研究的興起、慢性病盛行率的增加、技術進步和個人化醫療方法是預計在預測期內推動全球巨噬細胞標記市場成長的關鍵因素。
例如，印度國家生物技術資訊中心 2022 年 6 月發布的一份報告稱，印度約 21% 的老年人患有至少一種慢性疾病。
同時，根據國際抗癌聯盟2020年12月發布的報告，全球整體每五人中就有一人會在一生中罹患癌症，每八名男性中就有一人、每十一名女性中就有一人會死於癌症。
然而，巨噬細胞異質性的複雜性、缺乏特異性和敏感性以及有效抗體的有限性預計將在預測期內阻礙全球巨噬細胞標記市場的成長。

研究的主要特點

本報告對全球巨噬細胞標記市場進行了詳細分析，並以 2024 年為基準年，給出了預測期 2025-2032 的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數，介紹了全球巨噬細胞標誌物市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球巨噬細胞標誌物市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過全球巨噬細胞標記市場分析中使用的各種策略矩陣來做出決策。

介紹
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- 東南亞國協
- 其他亞太地區
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 南非
- 北非
- 中部非洲

第10章競爭格局

Abcam plc
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.
BD Biosciences
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
BioLegend, Inc.
Merck KGaA
Novus Biologicals, LLC
R&D Systems, Inc.（Bio-Techne品牌）
Santa Cruz BIoTechnology, Inc.
Beckman Coulter, Inc.
Miltenyi BIoTec GmbH
GeneTex, Inc.
MBL International Corporation

第 11 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI5945

Macrophage Marker Market is estimated to be valued at USD 290.3 Mn in 2025 and is expected to reach USD 451.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 290.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 451.1 Mn

Macrophages are white blood cells that play a key role in immunity and homeostasis. They act as first responders, ingesting foreign materials, microbes, and debris. Due to their importance, it is essential to characterize and study macrophage biology. Macrophage markers allow researchers to identify, isolate, track, and target these cells. There are two main types of macrophage markers. The first are cell surface markers, which are proteins expressed on the outer membrane of macrophages that can be detected using fluorescence-activated cell sorting or immunohistochemistry techniques. Common macrophage cell surface markers include CD68, CD14, CD163, and CD206. The second type are intracellular markers, which are proteins located inside macrophage cells.

Intracellular markers provide information about macrophage activation and function but require fixed and permeabilized cells. Cell surface markers have the advantage of allowing live cell analysis, isolation, and potentially targeting of macrophages. However, no single marker is specific enough to uniquely identify macrophages, and marker expression can change depending on activation state and tissue environment. Ideally, a combination of several markers is used to accurately characterize macrophage phenotypes and populations. The global market offers a wide variety of monoclonal antibodies against macrophage markers, aiding fundamental and applied research seeking new treatment strategies across medical conditions.

Market Dynamics

Increasing research in immunology, the growing prevalence of chronic diseases, technological advancements, and personalized medicine approaches are major factors expected to drive growth of the global macrophage marker market during the forecast period.
For instance, in June 2022, according to a report published by the National Center for Biotechnology information, approximately 21% of the elderly in India reportedly have at least one chronic disease.
While, in December 2020, according to a report published by the Union for International Cancer Control, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease.
However, the complexity of macrophage heterogeneity, a lack of specificity and sensitivity, and the limited availability of validated antibodies are expected to hamper growth of the global macrophage marker market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global macrophage marker market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global macrophage marker market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global macrophage marker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global macrophage marker market

Macrophage Marker Market Detailed Segmentation:

By Marker Type:
- CD68
- CD163
- CD206
- CD14
- CD11b
- CD64
- CD11c
- Others
By Application:
- Research Use
- Diagnostic Use
- Drug Development
By Disease Area:
- Oncology
- Infectious Diseases
- Autoimmune Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
By End User:
- Research Institutes and Academic Centers
- Pharmaceutical and Biotechnology Companies
- Clinical and Diagnostic Laboratories
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Abcam plc
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- BD Biosciences
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- BioLegend, Inc.
- Merck KGaA
- Novus Biologicals, LLC
- R&D Systems, Inc. (a Bio-Techne brand)
- Santa Cruz Biotechnology, Inc.
- Beckman Coulter, Inc.
- Miltenyi Biotec GmbH
- GeneTex, Inc.
- MBL International Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Macrophage Marker, By Marker Type
- Market Macrophage Marker, By Application
- Market Macrophage Marker, By Disease Area
- Market Macrophage Marker, By End User
- Market Macrophage Marker, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Macrophage Marker Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Macrophage Marker Market, By Marker Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
CD68
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD163
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD206
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD14
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD11b
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD64
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
CD11c
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Macrophage Marker Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Research Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Diagnostic Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Drug Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Macrophage Marker Market, By Disease Area, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Macrophage Marker Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Research Institutes and Academic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Clinical and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Macrophage Marker Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2028
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Abcam plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cell Signaling Technology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BD Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioLegend, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novus Biologicals, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
R&D Systems, Inc. (a Bio-Techne brand)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Santa Cruz Biotechnology, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Miltenyi Biotec GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GeneTex, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MBL International Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

集落刺激因子（CSF）治療市場：現況分析與預測（2024-2032）

FAQ

巨噬細胞標記物市場按標記物類型、應用、疾病領域、最終用戶和地區分類

Macrophage Marker Market, By Marker Type, By Application, By Disease Area, By End User, By Geography

市場動態

研究的主要特點

目錄

第1章調查目的與前提條件

第2章市場展望

第3章市場動態、法規與趨勢分析

第4章全球巨噬細胞標記市場-冠狀病毒（COVID-19）大流行的影響

5. 全球巨噬細胞標記市場（依標記類型），2020 年至 2032 年

6. 全球巨噬細胞標記市場（按應用），2020 年至 2032 年

7. 2020 年至 2032 年按疾病領域分類的全球巨噬細胞標記市場

8. 全球巨噬細胞標記市場（依最終用戶分類），2020 年至 2032 年

9. 全球巨噬細胞標記市場（按地區），2020 年至 2032 年

第10章競爭格局

第 11 章章節

Market Dynamics

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Macrophage Marker Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Macrophage Marker Market, By Marker Type, 2020-2032, (US$ Mn)

6. Global Macrophage Marker Market, By Application, 2020-2032, (US$ Mn)

7. Global Macrophage Marker Market, By Disease Area, 2020-2032, (US$ Mn)

8. Global Macrophage Marker Market, By End User, 2020-2032, (US$ Mn)

9. Global Macrophage Marker Market, By Region, 2020-2032, (US$ Mn)

10. Competitive Landscape

11. Section

巨噬細胞標記物市場按標記物類型、應用、疾病領域、最終用戶和地區分類

Macrophage Marker Market, By Marker Type, By Application, By Disease Area, By End User, By Geography

市場動態

研究的主要特點

目錄

第1章 調查目的與前提條件

第2章 市場展望

第3章市場動態、法規與趨勢分析

第4章 全球巨噬細胞標記市場-冠狀病毒（COVID-19）大流行的影響

5. 全球巨噬細胞標記市場（依標記類型），2020 年至 2032 年

6. 全球巨噬細胞標記市場（按應用），2020 年至 2032 年

7. 2020 年至 2032 年按疾病領域分類的全球巨噬細胞標記市場

8. 全球巨噬細胞標記市場（依最終用戶分類），2020 年至 2032 年

9. 全球巨噬細胞標記市場（按地區），2020 年至 2032 年

第10章 競爭格局

第 11 章 章節

Market Dynamics

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Macrophage Marker Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Macrophage Marker Market, By Marker Type, 2020-2032, (US$ Mn)

6. Global Macrophage Marker Market, By Application, 2020-2032, (US$ Mn)

7. Global Macrophage Marker Market, By Disease Area, 2020-2032, (US$ Mn)

8. Global Macrophage Marker Market, By End User, 2020-2032, (US$ Mn)

9. Global Macrophage Marker Market, By Region, 2020-2032, (US$ Mn)

10. Competitive Landscape

11. Section

第1章調查目的與前提條件

第2章市場展望

第4章全球巨噬細胞標記市場-冠狀病毒（COVID-19）大流行的影響

第10章競爭格局

第 11 章章節